TY - JOUR
T1 - Can we perform rotational atherectomy in patients with severe aortic stenosis? Substudy from the OCEAN TAVI Registry
AU - Naganuma, Toru
AU - Kawamoto, Hiroyoshi
AU - Takagi, Kensuke
AU - Yabushita, Hiroto
AU - Mitomo, Satoru
AU - Watanabe, Yusuke
AU - Shirai, Shinichi
AU - Araki, Motoharu
AU - Tada, Norio
AU - Yamanaka, Futoshi
AU - Yamamoto, Masanori
AU - Onishi, Hirokazu
AU - Nakamura, Sunao
AU - Higashimori, Akihiro
AU - Tabata, Minoru
AU - Mizutani, Kazuki
AU - Ueno, Hiroshi
AU - Hayashida, Kentaro
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2017/7
Y1 - 2017/7
N2 - Purpose The aim of this study was to report the safety of coronary rotational atherectomy (RA) in patients with severe aortic stenosis (AS). RA in the clinical setting seems challenging because coronary slow flow leads to hemodynamic instability. Methods Between October 2013 and May 2016, 1401 patients in the Optimized transCathEter vAlvular iNtervention (OCEAN) registry in Japan underwent transcatheter aortic valve implantation (TAVI). The primary study endpoint was procedural success, defined as residual stenosis <20% with final Thrombolysis in Myocardial Infarction flow 3. Results Twenty-five patients who underwent RA for heavily calcified lesions were included in the study. Low left ventricular ejection fraction (<35%) was present in 3 (12%) patients. The left main stem was involved in 7 (28%) patients. All patients were treated under intravascular image guidance. Intra-aortic balloon pumping was used in 4 (16%) patients. Planned balloon aortic valvuloplasty (BAV) was performed during the same session in 4 (16%) patients. Transvenous catecholamine was used in 10 (40%) patients. The majority of patients underwent drug-eluting stent implantation following RA (n = 23, 92%). Procedural success was achieved in all patients. Subsequent device success was achieved in 24 (96%) patients, with no 30-day mortality following TAVI. Conclusions RA in patients with severe AS seems extremely challenging; however, this procedure appears to be safe if mechanical and drug supports are appropriately utilized and the procedure is performed under intravascular image guidance.
AB - Purpose The aim of this study was to report the safety of coronary rotational atherectomy (RA) in patients with severe aortic stenosis (AS). RA in the clinical setting seems challenging because coronary slow flow leads to hemodynamic instability. Methods Between October 2013 and May 2016, 1401 patients in the Optimized transCathEter vAlvular iNtervention (OCEAN) registry in Japan underwent transcatheter aortic valve implantation (TAVI). The primary study endpoint was procedural success, defined as residual stenosis <20% with final Thrombolysis in Myocardial Infarction flow 3. Results Twenty-five patients who underwent RA for heavily calcified lesions were included in the study. Low left ventricular ejection fraction (<35%) was present in 3 (12%) patients. The left main stem was involved in 7 (28%) patients. All patients were treated under intravascular image guidance. Intra-aortic balloon pumping was used in 4 (16%) patients. Planned balloon aortic valvuloplasty (BAV) was performed during the same session in 4 (16%) patients. Transvenous catecholamine was used in 10 (40%) patients. The majority of patients underwent drug-eluting stent implantation following RA (n = 23, 92%). Procedural success was achieved in all patients. Subsequent device success was achieved in 24 (96%) patients, with no 30-day mortality following TAVI. Conclusions RA in patients with severe AS seems extremely challenging; however, this procedure appears to be safe if mechanical and drug supports are appropriately utilized and the procedure is performed under intravascular image guidance.
KW - Aortic stenosis
KW - Rotational atherectomy
KW - Transcatheter aortic valve implantation
UR - http://www.scopus.com/inward/record.url?scp=85019683235&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019683235&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2017.02.018
DO - 10.1016/j.carrev.2017.02.018
M3 - Article
C2 - 28314673
AN - SCOPUS:85019683235
SN - 1553-8389
VL - 18
SP - 356
EP - 360
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
IS - 5
ER -